These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 9465799
1. Collaborative trial of prenatal thyrotropin-releasing hormone and corticosteroids for prevention of respiratory distress syndrome. Collaborative Santiago Surfactant Group. Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):33-9. PubMed ID: 9465799 [Abstract] [Full Text] [Related]
2. A randomized, controlled trial of antepartum thyrotropin-releasing hormone and betamethasone in the prevention of respiratory disease in preterm infants. Knight DB, Liggins GC, Wealthall SR. Am J Obstet Gynecol; 1994 Jul; 171(1):11-6. PubMed ID: 8030684 [Abstract] [Full Text] [Related]
3. Dose response of thyrotropin-releasing hormone on pulmonary maturation in corticosteroid-treated preterm rabbits. Tabor BL, Ikegami M, Jobe AH, Yamada T, Oetomo SB. Am J Obstet Gynecol; 1990 Aug; 163(2):669-76. PubMed ID: 2117393 [Abstract] [Full Text] [Related]
4. Antenatal thyrotropin-releasing hormone to prevent lung disease in preterm infants. North American Thyrotropin-Releasing Hormone Study Group. Ballard RA, Ballard PL, Cnaan A, Pinto-Martin J, Davis DJ, Padbury JF, Phibbs RH, Parer JT, Hart MC, Mannino FL, Sawai SK. N Engl J Med; 1998 Feb 19; 338(8):493-8. PubMed ID: 9468465 [Abstract] [Full Text] [Related]
5. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings NJ, Jung AL, Kimberlin LV, Auten RL, Rosenberg AA, Asselin JM, Belcastro MR, Donohue PK, Hamm CR, Jansen RD, Brody AS, Riddlesberger MM, Montgomery P. Pediatrics; 1997 Jul 19; 100(1):39-50. PubMed ID: 9200358 [Abstract] [Full Text] [Related]
6. Fetal lung maturation: the combined use of corticosteroids and thyrotropin-releasing hormone. Morales WJ, O'Brien WF, Angel JL, Knuppel RA, Sawai S. Obstet Gynecol; 1989 Jan 19; 73(1):111-6. PubMed ID: 2491766 [Abstract] [Full Text] [Related]
10. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W, Corbet A, Cotton R, Courtney S, McGuiness G, Walter D, Watts J, Smyth J, Bard H, Chernick V. N Engl J Med; 1991 Dec 12; 325(24):1696-703. PubMed ID: 1944470 [Abstract] [Full Text] [Related]
11. One-year follow-up of 273 infants with birth weights of 700 to 1100 grams after prophylactic treatment of respiratory distress syndrome with synthetic surfactant or air placebo. American Exosurf Neonatal Study Group I. Sell M, Cotton R, Hirata T, Guthrie R, LeBlanc M, Mammel M, Long W. J Pediatr; 1995 May 12; 126(5 Pt 2):S20-5. PubMed ID: 7745507 [Abstract] [Full Text] [Related]
12. Thyrotropin-releasing hormone added to corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Crowther CA, Alfirevic Z, Haslam RR. Cochrane Database Syst Rev; 2004 May 12; (2):CD000019. PubMed ID: 15106139 [Abstract] [Full Text] [Related]
13. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group. Online J Curr Clin Trials; 1992 Nov 10; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614 [Abstract] [Full Text] [Related]